CCR5 Blockade modulates alloimmunity in primates

被引：0
|
作者：
DeMartino, Julie A. [1 ]
机构：
[1] Merck Res Labs, Rahway, NJ 07065 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 231卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
193-MEDI
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Why CCR2 and CCR5 Blockade Failed and Why CCR1 Blockade Might Still Be Effective in the Treatment of Rheumatoid Arthritis
    Lebre, Maria C.
    Vergunst, Clarissa E.
    Choi, Ivy Y. K.
    Aarrass, Saida
    Oliveira, Ana S. F.
    Wyant, Tim
    Horuk, Richard
    Reedquist, Kris A.
    Tak, Paul P.
    PLOS ONE, 2011, 6 (07):
  • [22] Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES
    Nardese, V
    Longhi, R
    Polo, S
    Sironi, F
    Arcelloni, C
    Paroni, R
    DeSantis, C
    Sarmientos, P
    Rizzi, M
    Bolognesi, M
    Pavone, V
    Lusso, P
    NATURE STRUCTURAL BIOLOGY, 2001, 8 (07) : 611 - 615
  • [23] Synergism between CCR5 blockade and CsA in primate cardiac allotransplantation.
    Pierson, RN
    Nguyen, BN
    Schroeder, C
    Wu, G
    Springer, M
    Lyons, K
    Peterson, L
    Azimzadeh, A
    DeMartino, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 179 - 179
  • [24] Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES
    Vanessa Nardese
    Renato Longhi
    Simona Polo
    Francesca Sironi
    Cinzia Arcelloni
    Rita Paroni
    Claudio DeSantis
    Paolo Sarmientos
    Menico Rizzi
    Martino Bolognesi
    Vincenzo Pavone
    Paolo Lusso
    Nature Structural Biology, 2001, 8 : 611 - 615
  • [25] Preventing HIV transmission through blockade of CCR5: rationale, progress and perspectives
    Elsa, Martins
    Ilaria, Scurci
    Oliver, Hartley
    SWISS MEDICAL WEEKLY, 2018, 148
  • [26] MODELING A CURE FOR HIV IN NONHUMAN PRIMATES USING CCR5 DISRUPTION GENE THERAPY
    Peterson, Christopher W.
    Younan, Patrick M.
    Wang, Jianbin
    Polacino, Patricia
    Holmes, Michael
    Gregory, Phillip
    Hu, Shiu-Lok
    Kiem, Hans-Peter
    JOURNAL OF MEDICAL PRIMATOLOGY, 2014, 43 (05) : 381 - 381
  • [27] The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations
    Zare-Bidaki, Mohammad
    Karimi-Googheri, Masoud
    Hassanshahi, Gholamhossein
    Zainodini, Nahid
    Arababadi, Mohammad Kazemi
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2015, 18 (04) : 312 - 316
  • [28] Effects of CC chemokine receptor 5 (CCR5) inhibitors on the dynamics of CCR5 and CC-chemokine-CCR5 interactions
    Nakata, Hirotomo
    Kruhlak, Michael
    Kamata, Wakako
    Ogata-Aoki, Hiromi
    Li, Jianfeng
    Maeda, Kenji
    Ghosh, Arun K.
    Mitsuya, Hiroaki
    ANTIVIRAL THERAPY, 2010, 15 (03) : 321 - 331
  • [29] CCR5 and inflammatory storm
    Lin, Yuting
    Liu, Shasha
    Sun, Yang
    Chen, Chen
    Yang, Songwei
    Pei, Gang
    Lin, Meiyu
    Yu, Jingbo
    Liu, Xuan
    Wang, Huiqin
    Long, Junpeng
    Yan, Qian
    Liang, Jinping
    Yao, Jiao
    Yi, Fan
    Meng, Lei
    Tan, Yong
    Chen, Naihong
    Yang, Yantao
    Ai, Qidi
    AGEING RESEARCH REVIEWS, 2024, 96
  • [30] PHARMACOLOGICAL BLOCKADE OF CCR1 AND CCR5 DIMINISHED NEUROPATHIC PAIN AND ENHANCED MORPHINE/BUPRENORPHINE EFFECTIVENESS
    Pawlik, K.
    Piotrowska, A.
    Kwiatkowski, K.
    Ciapala, K.
    Makuch, W.
    Mika, J.
    INFLAMMATION RESEARCH, 2019, 68 : 11 - 11
12345